RTW Biotech Opportunities (LON:RTW – Get Free Report) shares traded up 1.4% during trading on Monday . The stock traded as high as GBX 2.22 and last traded at GBX 2.19. 43,931 shares changed hands during trading, a decline of 93% from the average session volume of 608,552 shares. The stock had previously closed at GBX 2.16.
RTW Biotech Opportunities Stock Down 1.4%
The firm has a market cap of £7.06 million, a PE ratio of -0.08 and a beta of 0.60. The stock has a 50 day moving average price of GBX 1.94 and a two-hundred day moving average price of GBX 1.58.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Read More
- Five stocks we like better than RTW Biotech Opportunities
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
